Fluticasone Furoate

Adults: Fluticasone Furoate Nasal Spray: Adults and children over 12 years should use 2 sprays in each nostril once a day. In some cases, 2 sprays into each nostril twice daily may be used, not exceeding 4 sprays. Children under 12 years (2 to 11 years) should use 1 spray in each nostril once a day. Patients should use Fluticasone Furoate nasal spray at regular intervals as directed, since its effectiveness depends on regular use. Children under 2 years of age: there are no data to recommend the use of Fluticasone Furoate Nasal Spray for the treatment of seasonal or perennial allergic rhinitis in children under 2 years of age. Fluticasone Furoate Inhalation Capsule: this should be administered as 1 inhalation once daily by the orally inhaled route. Fluticasone Furoate should be used at the same time every day. Do not use fluticasone furoate more than 1 time every 24 hours. Adults and adolescents aged 12 years and older: the starting dosage of Fluticasone Furoate should be based on the patient's asthma severity. The usual recommended starting dose for adults and adolescents aged 12 years and older who are not on an inhaled corticosteroid (ICS) is 100 mcg. For other adults and adolescents aged 12 years and older, the starting dose should be based on previous asthma drug therapy and disease severity. For adults and adolescents aged 12 years and older who do not respond to Fluticasone Furoate 100 mcg after 2 weeks of therapy, replacement with Fluticasone Furoate 200 mcg may provide additional asthma control. If a dosage regimen of Fluticasone Furoate fails to provide adequate control of asthma, the therapeutic regimen should be re-evaluated and additional therapeutic options should be considered, for example replacing the current strength of Fluticasone Furoate with a higher strength, initiating an ICS and long-acting beta 2-agonist (LABA) combination product, or initiating oral corticosteroids. The highest recommended daily dose in adults and adolescents aged 12 years and older is 200 mcg. After asthma stability has been achieved, it is desirable to titrate to the lowest effective dosage to help reduce the possibility of side effects. Pediatric patients aged 5 to 11 years: the recommended dosage for children aged 5 to 11 years is 50 mcg administered once daily.